Clinical Trial Update: Exploratory Clinical Study of Claudin18.2-Targeted Activated DC and CAR-T Therapy in Advanced Pancreatic Cancer. [EARLY_Phase 1]

View source ↗

Summary

An early-phase exploratory clinical study is evaluating Claudin18.2-targeted Activated Dendritic Cells and Claudin18.2-targeted CAR-T therapy in patients with a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• Claudin18.2-targeted Activated Dendritic Cells
• Claudin18.2-targeted CAR-T Therapy

Snippet

Sponsor: Hainan Cancer Hospital | Conditions: Advanced Pancreatic Cancer | EARLY_Phase 1 | Status: RECRUITING